Figures & data
![](/cms/asset/5c1ca2ba-7390-4e67-8af7-2b2c55b31c65/kbie_a_2063592_uf0001_oc.jpg)
Figure 1. SNHG10 is downregulated in triple-negative breast cancer and is further downregulated by doxorubicin treatment. The expression levels of SNHG10 in triple-negative breast cancer (TNBC) tissues and adjacent non-tumor tissues before treatment were measured by RT-qPCR. The expression levels of SNHG10 in TNBC tissues were also measured by RT-qPCR after doxorubicin treatment. All reactions were performed in triplicate, and a paired t test was used to compare the mean values between the two tissue types and two time points. *, p < 0.05; ***, p < 0.001.
![Figure 1. SNHG10 is downregulated in triple-negative breast cancer and is further downregulated by doxorubicin treatment. The expression levels of SNHG10 in triple-negative breast cancer (TNBC) tissues and adjacent non-tumor tissues before treatment were measured by RT-qPCR. The expression levels of SNHG10 in TNBC tissues were also measured by RT-qPCR after doxorubicin treatment. All reactions were performed in triplicate, and a paired t test was used to compare the mean values between the two tissue types and two time points. *, p < 0.05; ***, p < 0.001.](/cms/asset/c6205e57-fd31-44ad-b052-33d1b24e2a49/kbie_a_2063592_f0001_oc.jpg)
Figure 2. MiR-302b is downregulated in TNBC and is positively correlated with SNHG10. The expression levels of miR-302b in both TNBC and adjacent non-tumor tissues were measured by RT-qPCR. All reactions were performed in triplicate, and a paired t test was used to compare the mean values between the two types of tissues (a). ***, p < 0.001. Correlations between the expression levels of SNHG10 and miR-302b in TNBC tissues (b) and non-tumor tissues (c) were analyzed by linear regression.
![Figure 2. MiR-302b is downregulated in TNBC and is positively correlated with SNHG10. The expression levels of miR-302b in both TNBC and adjacent non-tumor tissues were measured by RT-qPCR. All reactions were performed in triplicate, and a paired t test was used to compare the mean values between the two types of tissues (a). ***, p < 0.001. Correlations between the expression levels of SNHG10 and miR-302b in TNBC tissues (b) and non-tumor tissues (c) were analyzed by linear regression.](/cms/asset/f80adde4-723b-4ec6-b4f9-8a32b93414c0/kbie_a_2063592_f0002_oc.jpg)
Figure 3. SNHG10 upregulates miR-302b levels through methylation. BT-549 and MDA-MB-157 cells were transfected with either a miR-302b mimic or SNHG10 expression vector, and overexpression was confirmed by RT-qPCR 48 h later (a). The effects of miR-302b overexpression on the expression of SNHG10 (b) and the effects of SNHG10 overexpression on miR-302b (c) were also analyzed by RT-qPCR. Methylation-specific PCR analysis of the miR-302b gene. U refers to the U6 control, and M refers to miR-302b. (d). *, p < 0.05.
![Figure 3. SNHG10 upregulates miR-302b levels through methylation. BT-549 and MDA-MB-157 cells were transfected with either a miR-302b mimic or SNHG10 expression vector, and overexpression was confirmed by RT-qPCR 48 h later (a). The effects of miR-302b overexpression on the expression of SNHG10 (b) and the effects of SNHG10 overexpression on miR-302b (c) were also analyzed by RT-qPCR. Methylation-specific PCR analysis of the miR-302b gene. U refers to the U6 control, and M refers to miR-302b. (d). *, p < 0.05.](/cms/asset/6a7c464f-94dd-459e-a292-146b15fd5383/kbie_a_2063592_f0003_oc.jpg)
Figure 4. SNHG10 and miR-302b promote doxorubicin-induced TNBC cell apoptosis. BT-549 and MDA-MB-157 cells were treated with doxorubicin at doses of 0, 1, 5 and 10 ng/ml for 48 h, and then the expression levels of SNHG10 were measured using RT-qPCR (a). A cell apoptosis assay was performed to analyze the effects of overexpression of SNHG10 and miR-20b on the apoptosis of BT-549 and MDA-MB-157 cells (b). *, p < 0.05.
![Figure 4. SNHG10 and miR-302b promote doxorubicin-induced TNBC cell apoptosis. BT-549 and MDA-MB-157 cells were treated with doxorubicin at doses of 0, 1, 5 and 10 ng/ml for 48 h, and then the expression levels of SNHG10 were measured using RT-qPCR (a). A cell apoptosis assay was performed to analyze the effects of overexpression of SNHG10 and miR-20b on the apoptosis of BT-549 and MDA-MB-157 cells (b). *, p < 0.05.](/cms/asset/f7aaf9fa-9b00-4fad-a5be-094c8b58aad8/kbie_a_2063592_f0004_oc.jpg)
Figure 5. SNHG10 and miR-302b regulates the proliferation and colony formation of BT-549 cell apoptosis. The proliferation (a) and colony formation of BC cells transfected with SNHG10 or co-transfected with SNHG10 and a miR-302b mimic was evaluated using the CCK-8 assay and colony formation assay, respectively. Colony formation assay (b) was used to evaluate the proliferation of TNBC cells transfected with SNHG10 or co-transfected with SNHG10 and a miR-320b mimic. **, p < 0.01.
![Figure 5. SNHG10 and miR-302b regulates the proliferation and colony formation of BT-549 cell apoptosis. The proliferation (a) and colony formation of BC cells transfected with SNHG10 or co-transfected with SNHG10 and a miR-302b mimic was evaluated using the CCK-8 assay and colony formation assay, respectively. Colony formation assay (b) was used to evaluate the proliferation of TNBC cells transfected with SNHG10 or co-transfected with SNHG10 and a miR-320b mimic. **, p < 0.01.](/cms/asset/c66e8f68-fb42-4f69-af4a-a85c4a4e71a2/kbie_a_2063592_f0005_oc.jpg)